Credit Suisse Downgrades Clover Biopharmaceuticals Ltd (2197:HK) to Neutral

November 25, 2022 10:19 PM EST
Get Alerts 2197:HK Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 32 | New: 9
Join SI Premium – FREE

Credit Suisse analyst Yang Huang downgraded Clover Biopharmaceuticals Ltd (2197:HK) from Outperform to Neutral with a price target of HK$4.80 (from HK$3.40).

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades, Intl Ratings